English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17744/20032 (89%)
Visitors : 7234956      Online Users : 317
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/31886

    標題: 創新止血加壓器對行經股動脈心導管術的止血效能探討
    The Effect of Innovative Hemostatic Device on Transfemoral Artery Catheterization
    作者: 黃友志
    貢獻者: 醫務管理系
    關鍵字: 心導管
    Cardiac Catheterization
    Femoral artery hemostasis device
    日期: 2018
    上傳時間: 2019-02-27 16:47:19 (UTC+8)
    摘要: 過去臨床照護經驗顯示股動脈路徑之冠狀動脈介入手術有止血不易,病人需長時間臥床,活動被限制,與發生術後血管併發症等缺點。創新股動脈止血加壓器的研發主要是為提升醫療照護品質與減少病人術後的不適感。本研究的主要目的為探討經股動脈穿刺術的手術患者在術後使用創新股動脈止血加壓器與傳統L型止血加壓器止血的差異性,並探討不同止血方式在合併症發生情形及疼痛舒適度的差別。
    The shortcomings of the femoral approach to cardiac catheterization are difficult hemostasis,easy-to-vascular complications and prolonged bed rest and restricted activity in the past of clinical care experience.The development of the novel femoral artery hemostasis device is mainly to improve the quality of medical care and reduce the discomfort of patients after surgery.The main purpose of this study was to investigate the difference in hemostasis between patients undergoing transfemoral puncture surgery using novel femoral hemostatic apparatus and conventional L-shaped hemostatic instrument and explore the difference between different hemostatic methods in the influence of complications and comfortability.
    This study adopted a prospective approach and selected 60 cases with transfemoral coronary diagnosis and treatment to analyze.We was assigned 30 cases into experimental group to use the novel femoral hemostatic device and 30 cases into control group to use the conventional L-shaped hemostatic instrument according to the aspiration of the patients.Data were gathered from March 2017 to February 2018.The firstly used the population attribute variable and the medical treatment variable to confirm homogeneity of the experimental group and the control group,and then used the chi-square test and the Mann-Whitney U test to analyze and evaluate the hemostasis differences of the experimental group and the control group in blood oxygen saturation,hemostasis time,complications and pain of postoperative.
    The study results showed that although there were not significant statistics differences between the experimental group and the control groupn in preoperative and postoperative to the blood oxygen saturation.However,the used of novel femoral artery hemostatic device in the hemostatic time,occurrence of complications,the degree pain and heavy and swelling of the affected limb,and feeling of the degree of back pain are better than the used conventional L-shaped hemostatic instrument.
    Based on the results that the innovative femoral artery hemostasis device has the advantages of the easy-to-operate,reduce incidence of swelling complication and reduced pain degree.The recommended as a safe and effective way to stop bleeding of the using novel femoral artery hemostatic device.
    關聯: 電子全文公開日期:2023-06-22,學年度:106, 72頁
    Appears in Collections:[醫務管理系(所)] 博碩士論文

    Files in This Item:

    File Description SizeFormat

    All items in CNU IR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback